A B S T R A C T We have previously demonstrated that 3,5,3'-triiodothyronine (T3), whether administered in vivo or added to suspending media in vitro, promptly stimulates the in vitro accumulation of the nonmetabolized amino acids, alpha-aminoisobutyric acid, and cycloleucine (CLE) by thymocytes isolated from weanling rats. In these studies, we have examined the in vitro interaction between catecholamines and T3 with respect to this effect. The previously reported enhancement of CLE accumulation in thymocytes by T3 in vitro (1 ,uM) was confirmed. When added alone in concentrations ranging between 10 nM and 0.1 mM, the adrenergic agonists, epinephrine and norepinephrine, had no effect on CLE accumulation. At a concentration of 1 ,uM, isoproterenol, terbutaline, and phenylephrine were also without effect. However, the effect of T3 was clearly potentiated by the concomitant addition of epinephrine, norepinephrine, and possibly isoproterenol, whereas terbutaline and phenylephrine were without effect. Neither basal nor T3-enhanced CLE accumulation was affected by the addition alone of the adrenergic blocking agents, propranolol (0.1 mM), phentolamine (10 ,uM), or practolol (0.1 mM). Nevertheless, the beta1-and beta2-antagonist, propranol, and the beta,-antagonist, practolol, blocked the increment in CLE accumulation produced by epinephrine; the alpha-antagonist, phentolamine, was without effect.
1172 the other hand, neither T3 alone nor T3 plus epinephrine appreciably altered the rate of inward transport of CLE. As judged from studies of the ability ofthymocytes to exclude trypan blue, neither T3 alone nor T3 plus epinephrine either enhanced or impaired viability of cells during 3-h periods of incubation. Cell water content, measured with [3H]urea, was unaffected by T3, either alone or in the presence of epinephrine. In confirmation of previous results, the stimulatory effect ofT3 on CLE accumulation was unaffected by concentrations of puromycin sufficient to inhibit protein synthesis by at least 95%, and the potentiating action of epinephrine on the response to T3 was similarly unaffected.
From these findings, it is concluded that the effect of T3 to increase CLE accumulation by thymocytes in vitro, though itselfindependent ofadrenergic mediation, is potentiated by beta1-adrenergic stimulation. This interaction appears distinctly different from other thyroid hormone-catecholamine interactions, in which thyroid hormones enhance physiological responses to catecholamines. Its mechanism remains unclear, but the properties of the T3 effect, and possibly the interaction itself, suggest that T3 enhances CLE accumulation by an action at the level of the cell membrane.
INTRODUCTION
A number of questions concerning the actions of the thyroid hormones have long been under investigation but remain, nevertheless, incompletely clarified. Among these are questions concerning the primary mechanism of thyroid action at the cellular and subcellular levels; others concern the nature of the interaction between thyroid hormones and catecholamines that is so apparent in many physiological and clinical settings (1) (2) (3) . With respect to the primary locus ofthyroid hormone action, numerous data suggest a direct action at the nuclear level to modify gene expression (4) (5) (6) (7) . Still other data raise the possibility that high affinity receptors for thyroid hormone exist within the mitochondrion and that thyroid hormones exert a direct effect on mitochondrial function (8) (9) (10) . Data recently acquired by ourselves and others also support a direct, extranuclear action of thyroid hormones. Thus, in vitro, thyroid hormones enhance the accumulation of the nonmetabolized amino acids, alpha-aminoisobutyric acid, and 1-amino-cyclopentane-1-carboxylic acid (cycloleucine [CLE])1 by both chick embryo cartilage (11, 12) and rat thymocytes (13, 14) , and also increase the transport of the glucose analogue, 2-deoxy-D-glucose, by chick embryo myocardium in culture (15) and by freshly isolated rat thymocytes (16) . These effects ofthyroid hormone appear very promptly and are unaffected by inhibitors of protein or RNA synthesis, or both. Both the nature and promptness of these effects point to an action of thyroid hormone on the cell membrane or on membrane-mediated function.
In these studies, we have extended our earlier observations concerning the stimulatory effect of 3,5,3'-triiodothyronine (T3) on the accumulation of CLE by rat thymocytes in vitro and have explored the interactions between T3 and catecholamines within this system. The data reveal a previously unknown and possibly unique interaction in which certain catecholamines, though themselves without effect, act promptly to enhance the increase in CLE accumulation produced by T3.
METHODS
Experiments were performed in thymocytes isolated from female CD rats purchased from Charles River Breeding Laboratories, Wilmington, Mass. Animals were 21 d old at the time of arrival and were fed Purina Laboratory Chow (Ralston Purina Co., Inc., St. Louis, Mo.) and given tap water to drink ad libitum until the time of sacrifice, which occurred between 2 and 8 d after arrival of animals in the laboratory.
On the day of each experiment, a single rat was decapitated and allowed to exsanguinate. The thymus gland was then quickly but gently removed, and thymocytes were isolated by the general technique previously employed in this laboratory (17) . The gland was placed into a Petri dish standing on crushed ice and containing ice-cold buffer. The buffer employed contained the following: 120 mM NaCl; 5 mM KCI; 1 mM CaCl2; 2.5 mM MgCl2; 1.5 mM NaH2PO4; 25mM Tris-HCl; 20mM Hepes; and 22 mM glucose at pH 7.5.
Cells were freed from the thymus by gentle teasing with forceps, and when the liquid phase had become cloudy it was aspirated and filtered through nylon mesh. The filtrate was then centrifuged at 100 g for 20 min at 4°C, the supemate discarded, and the thymocyte pellet resuspended in 20 ml of cold buffer. Cells were then counted in a hemocytometer, and 1 Abbreviations used in this paper: CLE, cycloleucine; T3, 3,5,3'-triiodothyronine. epinephrine, was assessed. Cells were preincubated for 15 min, after which puromycin was added to one-half of the vessels at a concentration (100 Zg/ml) previously shown to inhibit amino acid incorporation into thymocyte protein under similar conditions of incubation by 95% (16) . After 10 min, certain of the vessels were enriched with T3 (1 ,uM) In other experiments, control vessels and vessels containing either T3 (1 ,uM) or T3 plus epinephrine (1 ,uM) were incubated for 3 h with trypan blue (0.3%). Aggregation or disaggregation of the cells, as well as their ability to exclude trypan blue, was then assessed microscopically. (Table I) . Epinephrine and norepinephrine, in concentrations ranging between 10 nM and 100 ,uM, as well as isoproterenol, terbutaline, and phenylephrine at 1 ,uM, all failed to induce a significant change in CLE accumulation.
RESULTS

Effect ofadrenergic agonists
Effect of adrenergic agents on the action of T3 (Table II) . Studies were performed to ascertain whether the adrenergic agonists, though inactive alone, would alter the increase in CLE accumulation in thymocytes induced by T3. In these groups of experiments, with one exception, T3 was employed at a concentration of 1.0 ,uM, and a similar concentration was employed in the case of the adrenergic agonists.
The previously described effect of 1 (18) . Terbutaline and phenylephrine were entirely without effect. Three experiments were performed in which a lower dose of T3 (0.1 ,uM) was employed. As expected, no effect of T3 alone on CLE accumulation was observed, but, despite the small number of experiments performed, CLE accumulation in the presence ofepinephrine was significantly higher than in control vessels.
Effect of adrenergic antagonists (Table III) . Experiments were also performed to determine the effect of adrenergic antagonists on both basal and T3-stimulated CLE accumulation. Propranolol (0.1 mM), phentolamine (10 ,uM), and practolol (0.1 mM) all failed to influence basal CLE accumulation. Concen- Effect of adrenergic antagonists in the presence of T3 plus epinephrine (Table IV) . Experiments were then conducted to ascertain whether the adrenergic antagonists would influence the synergistic interaction between T3 and epinephrine already demonstrated. In these experiments, CLE accumulation was measured in control vessels, as well as in vessels containing T3 (1 ,uM), T3 plus epinephrine (1 ,uM) , and T3 plus both epinephrine and adrenergic antagonist. The concentrations of antagonists employed were the highest concentrations previously shown to be without effect on either basal or T3-increased CLE accumulation.
In these experiments, the well-documented effect of T3 to increase CLE accumulation was again observed (statistical significances not shown), and in each of the three groups of experiments dealing with the three antagonists studied, CLE accumulation in the presence of T3 plus epinephrine was significantly greater than that seen with T3 alone. Phentolamine (10 ,uM) data from the four experiments revealed significant differences in the efflux rates among all three experimental groups (Fig. 1) . No significant effect of T3, with or without epinephrine, on the influx of [14C]CLE into thymocytes was observed. In six experiments, the accumulation of CLE after 5 min averaged 6.0±2.4 (nanomoles per 109 cells; mean±-SD) in control specimens, 6.4+±2.9 in specimens incubated with T3 (1 ,uM), and 5.2+2.4 in specimens incubated with T3 plus epinephrine (1 uM).
Effect of puromycin. In four experiments, preincubation with puromycin (100 ug/ml) inhibited the 30-min accumulation of CLE in T3-and epinephrinefree control thymocytes by 11.4±0.3%, and the 
DISCUSSION
In these studies we have confirmed our earlier observations indicating that T3 in vitro is capable of enhancing the accumulation of the nonmetabolized amino acids, alpha-aiminoisobutyric acid and CLE, by thymocytes harvested fromn weanling rats, and that this effect is mainly a result of an inhibition of aimino acid efflux, rather than an enhancement of inward transport (13, 14) . We have, in addition, demonstrated that a variety of adrenergic agonists, thought to be active at either the alpha-or beta-adrenergic receptor, do not in themselves, over a wide range of concentrationis, significantly affect CLE accumiiulation. Despite this, certain of the adrenergic agonists, notably epinephrine and norepinephrine, proved capable of increasing the response to T3, an effect seen to result fromi an increase in the T3-mediated inhibition of CLE efflux. Moreover, at the concentrationis tested, several adrenergic antagonists were themuselves without effect on basal or T3-increased CLE accumiiulation, but propranolol and practolol among themn proved capable of abolishing the synergistic effect of epiniephrine.
Among the variety of repor-ted interactions between the thyroid hormones and adrenergic agonists (1-3), the presently described response appears, at least superficially, to be uni(lue. Previously described interactions, certain of which are discussed more fully below, canl be categorized as reflecting an enhanced response to catecholamiines in the presence of excess or additional thyroid hormone and a depressed response in states of thyroid hormone lack. It is generally stated, therefore, that thyroid hormones increase the sensitivity of cer-tain physiological systems that are responsive to catecholamines (2, 3) . In these studies of the in vitro accumulation of CLE by thymocytes, in contrast, T3 was stimulatory when added alone, and its effect was increased by the addition of epinephrine epinephrine 100 times higher than those which increased the effect of T3 failed to affect CLE accumulation when added alone. In this system, therefore, catecholamines potentiated the response to thyroid hormones, rather than vice versa.
As judged from conventional criteria (19) , the potentiating effect ofthe catecholamines on this action of T3 appeared to be mediated at the beta,-receptor.
A consistent enhancement of the T3 effect was produced by both epinephrine and norepinephrine, which interact with both alpha-and beta-receptors. However, phenylephrine, which is solely an alphaagonist, did not increase the effect of T3; and phentolamine, an alpha-antagonist, did not inhibit the potentiating action of epinephrine. Moreover, the effect of epinephrine was abolished by propranol, a betal-and beta2-antagonist. Finally, mediation at the beta-receptor was indicated both by the ability of practolol, a beta,-blocking agent, to abolish the effect of epinephrine and by the failure of terbutaline, a beta2-agonist, to potentiate the effect of T3.
The promptness of the interaction between T3 and catecholamines that we have described is not without precedent in previous reports. In rat epididymal adipose tissue, enhancement of epinephrine-induced lipolysis by T3 in vitro is evident in 15-30 min (20) (21) (22) . Furthermore, in the morphinized dog receiving a continuous infusion of isoproterenol, small doses of T3 have been shown to increase the maximum rate of left ventricular tension development within 16 min, though similar doses of T3 in the absence of isoproterenol infusion were without effect.3 Both this interaction in the heart and that in adipose tissue (23) , like the converse interaction that we now describe, apparently involve the beta-receptor, but little further is known of their mechanism.
A greater number of studies have been undertaken in efforts to explain the manner in which thyroid hormones act to enhance certain responses to adrenergic agents, but the ultimate mechanism or mechanisms remain uncertain, and data are contradictory in some respects. A review of the voluminous literature related to this topic is clearly beyond the scope of this report and, in any event, would not necessarily apply to the converse effect that we have seen in the thymocyte. Because hypothyroidism decreases and hyperthyroidism increases the increase in cyclic AMP induced by epinephrine in adipose tissue in vitro (24) , and because dibutyryl cyclic AMP increases the accumulation of CLE by thymocytes in vitro (13) , it might be thought that a greater cellular accumulation of cyclic AMP in the presence of T3 and epinephrine than of either alone might explain these findings. This is unlikely, however, because dibutyryl cyclic AMP increases the accumulation of alpha-aminoisobutyric acid by increasing influx (13) , whereas the potentiating action of epinephrine on CLE accumulation was demonstrably a result of an increase in the inhibition of CLE efflux that T3 produces.
A central question concerning these observations relates to their physiological relevance. This question arises because to demonstrate an increased accumulation of CLE by rat thymocytes in vitro, either high concentrations of T3 must be added directly (1 ,uM) or a large dose ofT3 (20 ,g/100 g body wt) must be given to rats before thymocyte isolation. Recently, however, we have been able to define conditions in which the T3-responsiveness of the thymocyte with respect to CLE accumulation is greatly increased. In thymocytes isolated from adrenalectomized rats, enhancement of CLE accumulation by T3 in vitro is produced by concentrations as low as 0.1 nM, and this effect of adrenalectomy is abolished by pretreatment of the donor animals with physiological replacement doses of glucocorticoid.4 Moreover, in the adrenalectomized rat, the quantity of T3 by single intravenous injection that is required to increase accumulation of CLE by subsequently isolated thymocytes is as low as the daily physiological replacement dose, 0.5 .ug/100 g body wt. Such sensitization of thymocytes from adrenalectomized animals to the effect of T3 is consonant with the well-documented in vivo antagonism between physiological quantities of thyroid hormones and glucocorticoids, as well as their contrary independent effects, with respect to the growth and function of the lymphoid tissue (25) (26) (27) . Such consonance suggests, in turn, that the effect ofT3 on amino acid accumulation that we are studying in vitro has its counterpart under physiologic circumstances in vivo. Additional evidence to this point is provided by the findings of Daniel et al. (28) , who report that after intravenous administration of leucine, valine, and lysine, accumulation of the free forms of these amino acids by brain and skeletal muscle is far lower in hypothyroid than in normal rats.
High concentrations of thyroid hormones are often, though not invariably (29) (30) (31) (20) (21) (22) . Similarly, hypothyroidism greatly damps a variety of cardiovascular responses to catecholamines (1-3), but in the fetal rat heart in organ culture, for example, enhancement of the contractile rate requires T3 concentrations of 0.1-10 ,M (32) . Previous authors have discussed the problems posed by, and possible explanations for, this discrepancy between in vivo and in vitro responses (14, 20) .
A further question concerning these observations is their possible implications with respect to the mechanism of action of the thyroid hormones. Neither the stimulatory effect of T3 on CLE accumulation nor the potentiation of this effect by epinephrine can be ascribed to nonspecific cytotoxicity of these agents. Thus, as judged from the ability of cells to exclude trypan blue, the viability of thymocytes was neither enhanced nor diminished by T3, either alone or in combination with epinephrine. Neither can a more subtle cytotoxic effect of T3 and epinephrine leading to an increase in cell water and in CLE diffusion space explain the stimulation of CLE accumulation because, as judged from studies with [14C]urea, total cell water in thymocyte suspensions was unaffected by T3 and epinephrine, either alone or in combination. Hence, more specific fundamental effects seem likely.
The stimulatory effects ofT3 on amino acid accumulation by chick embryonic bone and by thymocytes (12, 14) , as well as the effect of T3 to increase 2-deoxy-D-glucose uptake in both chick embryo myocardium (15) and rat thymocytes (16) , like the effect of T3 to enhance epinephrine-stimulated lipolysis (17) , are all independent of new protein synthesis. The same is true of the potentiating action of epinephrine on the stimulation of CLE accumulation in thymocytes by T3 that we have herein described. This, as well as the promptness of these effects, the fact that they relate to substrate influx or efflux, and the fact of their interaction with catecholamines, whose actions are thought to be mediated at the cell membrane, suggest that these actions of T3 in vitro also occur at the cell surface. The likelihood that this is the case is increased, it would appear, by the recent demonstration of high affinity, limited capacity binding sites for T3 in plasma membranes derived from rat liver (33) .
If it be granted that these in vitro effects of T3 have relevance to the physiologic actions of T3 in vivo, then we would suggest that thyroid hormones act at the nuclear level to alter gene expression, probably act directly on the mitochondrion, and act at the cell membrane as well. In this light, thyroid hormones would be seen to act at multiple loci to induce a coordinated response in which increased availability of substrate proceeds hand in hanid with increased energy metabolism and accelerated synthesis of specific proteins.
